| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.57B | 46.16B | 43.97B | 41.46B | 36.60B | 34.07B |
| Gross Profit | 27.88B | 27.88B | 26.80B | 25.60B | 22.61B | 22.26B |
| EBITDA | 8.20B | 8.44B | 8.77B | 9.55B | 7.09B | 5.81B |
| Net Income | 4.16B | 4.38B | 4.24B | 3.77B | 4.52B | 2.65B |
Balance Sheet | ||||||
| Total Assets | 44.48B | 45.49B | 46.30B | 46.29B | 44.11B | 43.65B |
| Cash, Cash Equivalents and Short-Term Investments | 14.27B | 16.72B | 18.99B | 19.85B | 17.26B | 18.50B |
| Total Debt | 5.93B | 6.38B | 9.33B | 12.03B | 10.71B | 15.94B |
| Total Liabilities | 15.55B | 15.85B | 19.11B | 21.51B | 21.48B | 23.22B |
| Stockholders Equity | 28.63B | 29.28B | 26.71B | 24.28B | 22.19B | 19.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.86B | 6.15B | 6.88B | 5.94B | 3.70B |
| Operating Cash Flow | 0.00 | 6.33B | 6.54B | 7.18B | 6.23B | 3.99B |
| Investing Cash Flow | 0.00 | -4.41B | -3.63B | -2.88B | -1.53B | -4.34B |
| Financing Cash Flow | 0.00 | -4.44B | -4.10B | -1.77B | -5.67B | 222.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥69.99B | 12.38 | 13.96% | 2.16% | 10.89% | -4.99% | |
77 Outperform | ¥71.98B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
73 Outperform | ¥49.14B | 9.37 | ― | 2.81% | 4.47% | 11.37% | |
72 Outperform | ¥50.64B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
68 Neutral | ¥31.92B | 20.63 | ― | 4.58% | 4.58% | -15.00% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥6.74B | 27.15 | ― | ― | 11.32% | ― |